Noninvasive assessment of characteristics of novel anti-HER2
Por um escritor misterioso
Descrição
Schematic diagram of the pET-22 expressing anti-HER2 scFv. The
A) Distribution of the log‐transformed serum anti‐HER2 autoantibody
Genomic analysis of plasma circulating tumor DNA in patients with heavily pretreated HER2 + metastatic breast cancer
Full article: Development of High-Loading Trastuzumab PLGA Nanoparticles: A Powerful Tool Against HER2 Positive Breast Cancer Cells
Cancers, Free Full-Text
Herceptin-Conjugated DOX-Fe3O4/P(NIPAM-AA-MAPEG) Nanogel System for HER2-Targeted Breast Cancer Treatment and Magnetic Resonance Imaging
Flow Chart of study. Download Scientific Diagram
Subtyping of metastatic breast cancer based on plasma circulating tumor DNA alterations: An observational, multicentre platform study - eClinicalMedicine
124I-labeled anti-CD147 antibody for noninvasive detection of CD147-positive pan-cancers: construction and preclinical studies
Treatment with trastuzumab deruxtecan in patients with HER2-positive breast cancer and brain metastases and/or leptomeningeal disease (ROSET-BM)
Patient-derived xenograft models in cancer therapy: technologies and applications
Clinical and translational relevance of intratumor heterogeneity: Trends in Cancer
Synthesis, Preclinical Validation, Dosimetry, and Toxicity of 68Ga-NOTA-Anti -HER2 Nanobodies for iPET Imaging of HER2 Receptor Expression in Cancer
Therapeutic strategy for anti-Her2 and Palbociclib resistant tumors
Cancers, Free Full-Text
de
por adulto (o preço varia de acordo com o tamanho do grupo)
